Sit.rep 2-2014

Situation report 2-2014

Growth strategy

Finalised during the current spring according to plan, the growth strategy of the healthcare innovation and research operations will position the pharmaceutical industry among the Finnish businesses in a completely new manner. The purpose of the growth strategy is to generate growth conditions for the research and innovation operations in health technology and pharmaceutical industry, recognising these operations as one of the pillars of new economic growth.

Read more...

--------------------------------------------------------------------------------

PIF investment survey:
Finland's opportunity to attract additional investments 

To probe the member companies’ views on Finland as a venue for investments, Pharma Industry Finland PIF made a survey on this question, first of its kind. The responses of the member companies suggest that Finland has certain strengths that attract companies to invest here. It will be possible to exploit the full potential of these strengths if the weaknesses in the operative environment are improved.

Read more...

--------------------------------------------------------------------------------

Advanced pharmacotherapies contribute to people's working capacity with positive impact on the whole economy

Postponing people’s retirement is currently one of the major objectives of the Government. The factors behind the objective are the public economy sustainability gap as well as the radically weaker dependency ratio as the baby-boomers are soon retiring. The number of tax-payers is decreasing to an excessive degree.

Read more...